Purifkation and Characterization of Elastase-Specific Inhibitor. Sequence Homology with Mucus Proteinase Inhibitor
about
sameAs
The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung diseaseCharacterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretionsThe trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide coreInnate immune defences in the human endometriumNeutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Post-cardiac transplant arteriopathy in piglets is associated with fragmentation of elastin and increased activity of a serine elastase.Functional study of elafin cleaved by Pseudomonas aeruginosa metalloproteinases.Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trialHuman rElafin Inhibits HIV-1 Replication in Its Natural Target Cells.Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation.Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.Expression of secretory leukocyte protease inhibitor and elafin in human fallopian tube and in an in-vitro model of Chlamydia trachomatis infection.WAP domain proteins as modulators of mucosal immunity.SLPI and elafin: multifunctional antiproteases of the WFDC family.Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.Antiproteases as therapeutics to target inflammation in cystic fibrosis.Trappin ovine molecule (TOM), the ovine ortholog of elafin, is an acute phase reactant in the lung.Human neutrophil elastase regulates the expression and secretion of elafin (elastase-specific inhibitor) in type II alveolar epithelial cells.Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines.Differential expression of SKALP/Elafin in human epidermal tumors.The antimicrobial antiproteinase elafin binds to lipopolysaccharide and modulates macrophage responses.The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function.Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3.Supernatants of Pseudomonas aeruginosa induce the Pseudomonas-specific antibiotic elafin in human keratinocytes.Characterization of the ovine ortholog of secretory leukoprotease inhibitor.
P2860
Q21146748-65E1698D-ADE8-4D58-8CBB-FFCE215C703FQ24324595-D48CBB2F-2411-4D20-8680-50097EBD18C7Q24531515-0BA35E58-E55F-4719-A63B-24DCA7235D12Q24801159-D559D3FD-920B-4E0D-A071-300C8533EBC7Q34149948-FCEEF893-0D53-4A86-B552-7ACE233CB0E4Q35833724-987CCADA-742F-4D2E-94D7-F5C5B78AC820Q36093198-55699951-A371-482B-8DED-B11B236E9097Q36209021-DB859E0E-0A64-4F90-A0BE-D7CCD4B3749DQ36750287-DB5FE8FD-2340-4198-8D40-E4167CC7A41FQ37355486-ABEF6DEB-F1C8-444D-9686-88BAFE0105F2Q37731798-5A41D923-AA7D-4BDD-962A-0A280C5A3C30Q37855924-F1AF6FBA-C8A7-470A-8341-0CC7AD671800Q37936531-CB34331F-5FF2-4EB4-81AF-DDC8DF9242C4Q37936541-5CF7A386-1DD4-499E-ADFE-1BCD2CAD483DQ38850115-793C87D3-1E2A-4256-9BCB-4BBAE8233A3CQ40363808-35025F73-B1F8-4C57-9D1C-6601BE0CC949Q40528803-84B2E775-5130-4A04-8D73-5990CC821A07Q40929072-C640E89A-208A-4E3F-AB6A-AF167036267DQ41575788-F171B4C6-70FB-47E8-B2F2-C3FA7F7383FFQ42133049-795515CB-CAE3-4831-9AF4-2E9DD789ED17Q45236699-B158CAF7-4DB7-43A0-B779-B6D2994FE074Q46701553-FA4473CA-B65B-4F81-BA09-80899ED2C355Q46798297-22367AA3-9558-49F4-AA9D-68228BC78412Q47675233-C7DE937C-D9BC-499D-8451-D756E29EAF41Q47723039-D73BAE4E-1E19-4AA9-B13B-710CE38A3732
P2860
Purifkation and Characterization of Elastase-Specific Inhibitor. Sequence Homology with Mucus Proteinase Inhibitor
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Purification and characterizat ...... ith mucus proteinase inhibitor
@nl
Purifkation and Characterizati ...... ith Mucus Proteinase Inhibitor
@ast
Purifkation and Characterizati ...... ith Mucus Proteinase Inhibitor
@en
Purifkation and Characterizati ...... ith Mucus Proteinase Inhibitor
@en-gb
type
label
Purification and characterizat ...... ith mucus proteinase inhibitor
@nl
Purifkation and Characterizati ...... ith Mucus Proteinase Inhibitor
@ast
Purifkation and Characterizati ...... ith Mucus Proteinase Inhibitor
@en
Purifkation and Characterizati ...... ith Mucus Proteinase Inhibitor
@en-gb
altLabel
Purification and characterizat ...... ith mucus proteinase inhibitor
@en
prefLabel
Purification and characterizat ...... ith mucus proteinase inhibitor
@nl
Purifkation and Characterizati ...... ith Mucus Proteinase Inhibitor
@ast
Purifkation and Characterizati ...... ith Mucus Proteinase Inhibitor
@en
Purifkation and Characterizati ...... ith Mucus Proteinase Inhibitor
@en-gb
P2093
P1476
Purification and characterizat ...... ith mucus proteinase inhibitor
@en
Purifkation and Characterizati ...... ith Mucus Proteinase Inhibitor
@en
P2093
Andrew P. RYLE
J M Sallenave
Jean-Michel SALLENAVE
P356
10.1515/BCHM3.1991.372.1.13
P407
P577
1991-01-01T00:00:00Z